87629-18-3 Usage
Molecular structure
1H-Pyrazolo[4,3-c]pyridine,1-ethyl-3-(4-fluorophenyl)-4,5,6,7-tetrahydro-, monomethanesulfonate has a complex molecular structure that includes a pyrazolo[4,3-c]pyridine ring, an ethyl group, a 4-fluorophenyl group, and a methanesulfonate group.
Heterocyclic compound
It is a heterocyclic compound, which means it contains at least one ring structure with atoms other than carbon, such as nitrogen or oxygen, in the ring.
Pharmaceutical properties
The compound exhibits pharmaceutical properties, which means it has potential for use in the development of drugs for treating various conditions.
Medicinal applications
It is used in medicinal applications, particularly in the development of drugs for treating neurological disorders, psychiatric conditions, and other central nervous system-related ailments.
Synthetic target
Its unique structure and properties make it an important target for synthetic chemists and pharmaceutical researchers in the quest for novel and effective drug candidates.
Check Digit Verification of cas no
The CAS Registry Mumber 87629-18-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,6,2 and 9 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 87629-18:
(7*8)+(6*7)+(5*6)+(4*2)+(3*9)+(2*1)+(1*8)=173
173 % 10 = 3
So 87629-18-3 is a valid CAS Registry Number.
87629-18-3Relevant academic research and scientific papers
Synthesis, in Vitro 3H>Prazosin Displacement, and in Vivo Activity of 3-Aryl-4,5,6,7-tetrahydropyrazolopyridines, a New Class of Antihypertensive Agents
Winters, Giorgio,Sala, Alberto,Barone, Domenico,Baldoli, Emiliana
, p. 934 - 940 (2007/10/02)
A series of a new 3-aryl-4,5,6,7-tetrahydropyrazolopyridines was synthesized and screened for in vitro 3H>prazosin displacement activity.The results correlated well with their antihypertensive activity in spontaneous hypertensive rats.
